Today's guest is Dr. Brooke Worster a Cancer Pain Management Doctor at Jefferson Health in Philadelphia and a cannabis researcher with Thomas Jefferson University. Her research interests focus on improving the quality of life for patients with serious illnesses.  This includes both the impact, risks, and benefits of cannabis compared to other prescription pharmacotherapy for pain and other burdensome symptoms as well as how to quantify and maximize the benefits of team-based interprofessional interactions for patients and their families.  ..read more

Lumenate is a pioneering app that uses sound and light to change brain rhythms in ways similar to psychedelics and highly experienced meditators, and brain imaging researchers at Imperial College London and as well as researchers in Berlin.  Our guests have talked about what psychedelic experiences and Lumenate appear to have in common. They talked about Increased brain signal complexity, reduced activity in the default mode network, increased functional connectivity between different brain regions, and reductions in peak alpha brainwaves.  They have ongoing trials underway in L ..read more

Dr. Cornblatt is a Johns Hopkins University School of Medicine Graduate with a Ph.D. in Pharmacology and Molecular Sciences and a postdoctoral fellowship from the Johns Hopkins Bloomberg School of Public Health, Environmental Health Sciences Division of Toxicology. Dr. Cornblatt has served as Director of Consumer Clinical Research and Science and as Medical Director at Nutramax Laboratories Consumer Care, Inc. In this role, Dr. Cornblatt developed novel nutraceutical formulations, designed both in vitro and clinical studies in support of products, and summarized both supporting laboratory and ..read more

Dr. Cornblatt is a Johns Hopkins University School of Medicine Graduate with a Ph.D. in Pharmacology and Molecular Sciences and a postdoctoral fellowship from the Johns Hopkins Bloomberg School of Public Health, Environmental Health Sciences Division of Toxicology. Dr. Cornblatt has served as Director of Consumer Clinical Research and Science and as Medical Director at Nutramax Laboratories Consumer Care, Inc. In this role, Dr. Cornblatt developed novel nutraceutical formulations, designed both in vitro and clinical studies in support of products, and summarized both supporting laboratory and ..read more

Silo Pharma merges traditional therapeutics with psychedelic research to develop innovative solutions that address a variety of underserved conditions including Alzheimer’s, Fibromyalgia, Parkinson’s, Multiple Sclerosis (MS), Rheumatoid Arthritis (RA), as well as stress-induced psychiatric disorders (i.e. PTSD) and other debilitating chronic conditions. We talk about the research and the conditions you choose to study in conjunction with psychedelic treatment.  Silo has partnered with several leading academic institutions (the University of California, San Francisco, Columbia University ..read more

Steven Twohig has been studying an abundance of practices extensively, including mindfulness, business optimization, shadow work and facilitation, Neuro-Linguistic Programming (NLP), hypnotherapy, and leadership dynamics. He recently has been researching psychedelic integration, which is defined as a process in which the patient integrates the insights of their experience into their life, and PHRI is a method of supporting that in the clinical consultation room. On Steven's website for Mastering Change, he wrote: “miscoding deep in the human mind. This coding is the root cause of all suff ..read more

Blake Pearson has been internationally recognized for his work in cannabis medicine and efforts to legitimize cannabinoid therapy as a safer alternative to opioids and anti-psychotic drugs. He has helped improve your patients’ symptoms with cannabinoid medicine and has been able to reduce the anti-psychotics. Dr. Blake recently announced the start of a new research study into the impact of cannabinoid therapy on local residents with dementia. He has partnered with Lambton College and Steeves & Rozema Nursing Homes for a three-year, $360,000 research grant from the National Sciences and Eng ..read more

The Stanley brothers celebrate the ten-year anniversary of providing their high-CBD and low-THC full-spectrum hemp formula to Charlotte Figi after her pediatrician supplied written permission. We talk about how Joel reflects on the help you were able to give Charlotte and how the industry as a whole has grown in the last decade. On April 7th 2020, after the unfortunate passing of Charlotte Figi, the Governor of California officially declared April 7th to be 'Charlotte Figi Day' in Colorado. Joel honors that day with the Charlotte Figi Family Grant Program to help health-seeking families with q ..read more

Joseph and his brother Chris are experts on both functional and psychedelic mushrooms and their health benefits, as well as biohacking and cognitive wellness. They've witnessed first-hand the effects that mushrooms had while they used them to treat their father, and using mushrooms yourselves. With that, we talk about Joseph and Chris's grandfather who had succumbed to Alzheimer’s disease and their father suffered from the same fate. Then they discovered they were next after genetic tests showed they had the strongest risk factor gene for Alzheimer's (ApoE4). So we talk about some of the work ..read more

Dr. Salzman is a physician, scientist, inventor, and biomedical entrepreneur with more than 30 years of experience in biomedical drug discovery and development. He has authored 175 peer-reviewed scientific publications and holds 60 patents in the fields of medicine, pharmacology, organic chemistry, and medical devices. Dr. Salzman has received continuous National Institutes of Health (NIH) funding since 1993, authoring 75 federal grants and receiving $160 million in federal grant and contract funding.  He earned his Doctor of Medicine degree from Harvard Medical School after completing un ..read more